Skip to main content
Caplight Logo









Pulsecare Medical

Pulsecare Medical

Private
ShenzhenHealthcare & Life Scienceshttp://pulsecare.cn/

Last Round

Series C

Aug 29, 2022

Est. Valuation

$14.49M

Total Funding Raised

$19.65M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Pulsecare Medical is a cardiovascular medical device company that develops and manufactures minimally invasive therapeutic technology, including its flagship nanosecond pulsed field ablation (nsPFA) system for treating atrial fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

pulsed field ablationPFAcardiac electrophysiologyatrial fibrillation treatmentrenal denervationRDNminimally invasive surgerymedical device manufacturersurgical disposablescatheter ablationinterventional cardiologytumor ablationrazor and bladeelectrophysiology labEP lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pulsecare Medical Comparables

Compare Pulsecare Medical with similar companies based on industry and business-model similarity.

Pulsecare Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnChannel Medical
86%
Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd.
81%
Field Medical
79%

Pulsecare Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 29, 2022
Series BDec 25, 2020
Series AMay 29, 2019
AngelDec 13, 2017

Pulsecare Medical Investors

Notable investors and investment history

Pulsecare Medical investors
InvestorRounds
Sunland FundSeries B
广东粤财创业投资有限公司Series C
China Merchants Zhiyuan Capital InvestmentSeries B
Welight CapitalSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2026

    Open roles increased to 33, 79% of headcount.

  • Feb 24, 2025

    Grew from 2 to 45 employees this quarter.

Pulsecare Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pulsecare Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pulsecare Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range42
Year Founded2021
Last FundingAug 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?